V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220020285 | 220005330 | 1.55 | 53.5 | Palliative (P) | null | 2018-04-11 | Nilotinib | N | N | 220020639 | NILOTINIB |
| 220020286 | 220005331 | 1.64 | 93 | Curative (C) | 2013-06-24 | 2013-09-21 | Cytarabine High Dose | 99 | null | 220020646 | CYTARABINE HIGH DOSE |
| 220020287 | 220005335 | null | null | Curative (C) | null | 2017-11-16 | Nilotinib | 02 | N | 220020649 | NILOTINIB |
| 220020288 | 220005338 | 1.18 | 16.4 | Curative (C) | null | 2018-05-02 | Cytarabine High Dose | null | N | 220020652 | CYTARABINE HIGH DOSE |
| 220020289 | 220005339 | null | 78.8 | Curative (C) | 2014-03-27 | 2014-07-10 | Cytarabine High Dose | 2 | N | 220020654 | CYTARABINE HIGH DOSE |
| 220020290 | 220005346 | 1.75 | 14.4 | Curative (C) | 2016-02-06 | 2016-02-06 | AML Int Guide HD Cytarabine (3 + 4) | 2 | N | 220020666 | CYTARABINE HIGH DOSE |
| 220020291 | 220005351 | 1.72 | 14 | Curative (C) | 2019-03-11 | 2019-03-11 | Cytarabine High Dose | N | N | 220020673 | CYTARABINE HIGH DOSE |
| 220020292 | 220005359 | 0 | null | Curative (C) | 2015-07-01 | 2015-07-06 | Nilotinib | 99 | null | 220020676 | NILOTINIB |
| 220020293 | 220005367 | 0 | 0 | Curative (C) | 2019-12-29 | 2019-12-29 | Nilotinib | 1 | N | 220020695 | NILOTINIB |
| 220020294 | 220005387 | 1.61 | 78.9 | Curative (C) | 2017-05-20 | 2017-05-20 | Nilotinib | N | N | 220020746 | NILOTINIB |
| 220020295 | 220005396 | 1.77 | 88.6 | Palliative (P) | 2016-06-17 | 2016-06-18 | Cytarabine High Dose | N | N | 220020760 | CYTARABINE HIGH DOSE |
| 220020296 | 220005399 | 0 | 99.7 | Curative (C) | 2017-08-05 | 2017-11-06 | AML Int Guide HD Cytarabine (3 + 4) | null | N | 220020766 | CYTARABINE HIGH DOSE |
| 220020297 | 220022178 | 1.86 | 78 | Not known (9) | 2015-08-25 | 2015-09-02 | Cytarabine High Dose | 2 | N | 220020779 | CYTARABINE HIGH DOSE |
| 220020298 | 220005408 | 1.71 | 71.5 | null | 2015-07-29 | 2015-07-29 | Cytarabine High Dose | N | N | 220020782 | CYTARABINE HIGH DOSE |
| 220020299 | 220005411 | 1.73 | 70 | Palliative (P) | 2017-11-22 | 2018-02-28 | Cytarabine High Dose | N | null | 220020794 | CYTARABINE HIGH DOSE |
| 220020301 | 220005418 | 1.94 | 75 | Curative (C) | 2013-05-13 | 2013-05-13 | FLAG + Idarubicin | N | N | 220020840 | FLAG + IDARUBICIN |
| 220020302 | 220005428 | 1.78 | 84.3 | Curative (C) | null | 2013-07-16 | AML17 TRIAL | N | N | 220020877 | AML17 TRIAL |
| 220020303 | 220005431 | 1.79 | 76.5 | Curative (C) | 2016-09-09 | 2016-10-11 | AML17 TRIAL | N | N | 220020879 | AML17 TRIAL |
| 220020304 | 220019375 | 1.79 | 58 | Curative (C) | 2018-05-22 | 2018-05-22 | AML17 TRIAL | N | N | 220020898 | AML17 TRIAL |
| 220020305 | 220012864 | 1.63 | 60 | Curative (C) | 2015-11-29 | 2016-02-09 | FLAG + Idarubicin | null | N | 220020912 | FLAG + IDARUBICIN |
| 220020306 | 220005448 | 1.65 | 68 | Curative (C) | 2018-07-27 | 2018-08-03 | FLAG + Idarubicin | 2 | N | 220020950 | FLAG + IDARUBICIN |
| 220020307 | 220020676 | 1.74 | 83 | Curative (C) | 2009-05-22 | 2014-01-15 | FLAG + Idarubicin | N | N | 220020957 | FLAG + IDARUBICIN |
| 220020308 | 220017059 | 1.52 | 85.6 | Curative (C) | 2015-01-16 | 2017-08-15 | AML17 TRIAL | 02 | N | 220020962 | AML17 TRIAL |
| 220020309 | 220005454 | 1.7 | 76.2 | Adjuvant (A) | 2015-09-08 | 2015-12-18 | AML17 TRIAL | Y | null | 220020971 | AML17 TRIAL |
| 220020310 | 220005456 | 1.74 | 75 | Disease modification (D) | 2015-07-17 | 2015-08-28 | FLAG + Idarubicin | Y | N | 220020977 | FLAG + IDARUBICIN |
| 220020312 | 220005463 | 1.67 | 97 | Adjuvant (A) | 2016-06-19 | 2017-07-26 | FLAG + Idarubicin | 2 | null | 220020990 | FLAG + IDARUBICIN |
| 220020313 | 220005479 | 1.72 | 121.5 | Curative (C) | 2016-12-14 | 2017-08-07 | FLAG + Idarubicin | 01 | Y | 220021037 | FLAG + IDARUBICIN |
| 220020314 | 220012891 | 1.67 | 51.7 | Curative (C) | 2014-05-20 | 2014-05-20 | FLAG + Idarubicin | N | null | 220021063 | FLAG + IDARUBICIN |
| 220020315 | 220005490 | 1.84 | 92.8 | Radical (R) | 2013-03-27 | 2013-03-30 | AML17 TRIAL | 1 | N | 220021082 | AML17 TRIAL |
| 220020317 | 220005510 | 0 | 55.2 | Adjuvant (A) | 2018-11-19 | 2018-11-22 | FLAG + Idarubicin | null | N | 220021137 | FLAG + IDARUBICIN |
| 220020319 | 220005517 | 1.71 | 60.2 | Curative (C) | 2017-06-21 | 2017-06-21 | FLAG + Idarubicin | N | N | 220021149 | FLAG + IDARUBICIN |
| 220020320 | 220012907 | 1.69 | 61.4 | Curative (C) | null | 2017-01-19 | FLAG + Idarubicin | 02 | N | 220021160 | FLAG + IDARUBICIN |
| 220020321 | 220005522 | 1.71 | 72.4 | Curative (C) | 2018-05-13 | 2018-05-31 | FLAG + Idarubicin | 02 | N | 220021161 | FLAG + IDARUBICIN |
| 220020322 | 220019392 | 1.7 | 86.9 | Curative (C) | 2016-03-28 | 2016-03-28 | AML17 TRIAL | N | N | 220021165 | AML17 TRIAL |
| 220020323 | 220005531 | 1.58 | 78.5 | Curative (C) | 2012-11-11 | 2014-02-07 | AML17 TRIAL | 2 | N | 220021175 | AML17 TRIAL |
| 220020324 | 220012924 | 1.57 | 74.2 | Curative (C) | 2016-10-27 | 2016-11-17 | AML17 TRIAL | N | N | 220021255 | AML17 TRIAL |
| 220020325 | 220005564 | 1.69 | 80 | Curative (C) | 2015-03-07 | 2015-03-07 | AML17 TRIAL | N | N | 220021284 | AML17 TRIAL |
| 220020326 | 220019398 | 1.63 | 95.7 | Curative (C) | 2014-12-18 | 2015-07-17 | AML17 TRIAL | 02 | N | 220021289 | AML17 TRIAL |
| 220020327 | 220005582 | 1.73 | 72.5 | Curative (C) | 2017-12-20 | 2018-02-28 | FLAG + Idarubicin | 02 | N | 220021341 | FLAG + IDARUBICIN |
| 220020328 | 220005588 | null | null | Disease modification (D) | 2017-09-26 | 2017-09-29 | AML17 TRIAL | 02 | N | 220021359 | AML17 TRIAL |
| 220020329 | 220005602 | 1.74 | 73 | Curative (C) | null | 2018-02-16 | FLAG + Idarubicin | N | Y | 220021394 | FLAG + IDARUBICIN |
| 220020330 | 220005606 | 0 | 98 | Curative (C) | 2016-10-09 | 2016-10-09 | AML Interim Guidelines FLAG-Ida | 02 | N | 220021411 | FLAG + IDARUBICIN |
| 220020331 | 220005611 | 1.87 | 65.4 | Curative (C) | 2017-02-16 | 2017-12-17 | FLAG + Idarubicin | 2 | N | 220021432 | FLAG + IDARUBICIN |
| 220020332 | 220005616 | 1.72 | 83.8 | Curative (C) | 2019-04-03 | 2019-04-09 | FLAG + Idarubicin | 02 | N | 220021441 | FLAG + IDARUBICIN |
| 220020333 | 220005619 | 1.75 | null | Curative (C) | 2018-03-17 | 2018-03-17 | AML17 TRIAL | 1 | N | 220021448 | AML17 TRIAL |
| 220020334 | 220005621 | 1.66 | 78 | Curative (C) | null | 2015-11-26 | AML Interim Guidelines FLAG-Ida | N | N | 220021453 | FLAG + IDARUBICIN |
| 220020335 | 220005633 | 1.6 | 58.3 | Disease modification (D) | 2019-03-02 | 2019-03-13 | FLAG + Idarubicin | N | N | 220021470 | FLAG + IDARUBICIN |
| 220020336 | 220005640 | 1.83 | 78 | Curative (C) | 2014-12-31 | 2015-02-05 | AML17 TRIAL | 2 | N | 220021478 | AML17 TRIAL |
| 220020337 | 220005644 | 1.76 | null | Curative (C) | 2018-02-03 | 2018-02-09 | FLAG + Idarubicin | N | N | 220021483 | FLAG + IDARUBICIN |
| 220020338 | 220005659 | 1.85 | 56.8 | Curative (C) | null | 2018-10-13 | AML17 TRIAL | null | N | 220021535 | AML17 TRIAL |